REQUEST A DEMO
Total
USD $0.00
Search more companies

Santander Medical Group S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Santander Medical Group S.A.S Profile Updated: April 08, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Santander Medical Group S.A.S is based in Colombia. The head office is in Bucaramanga. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 23, 2015. It currently has a total number of 48 (2026) employees. The company’s latest financial report indicates a net sales revenue increase of 41.77% in 2025. There was a total growth of 35.18% in Santander Medical Group S.A.S’s total assets over the same period. In 2025, Santander Medical Group S.A.S’s net profit margin decreased by 15.89%.

Headquarters
Carrera 32 # 49 - 76
Bucaramanga; Santander;

Contact Details: Purchase the Santander Medical Group S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Santander Medical Group S.A.S report to view the information.
Registered Capital:
Purchase the Santander Medical Group S.A.S report to view the information.
Financial Auditors:
Purchase the Santander Medical Group S.A.S report to view the information.
Incorporation Date:
September 23, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Santander Medical Group S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
41.77%
Total Operating Revenue
41.77%
Operating Profit
23.07%
EBITDA
21.26%
Net Profit/Loss for the Period
-21.7%
Total Assets
35.18%
Total Equity
38.05%
Operating Profit Margin
-4.99%
Net Profit Margin
-15.89%
Return on Equity (ROE)
-21.03%
Debt / Equity
8.41%
Quick Ratio
0.84%
Cash Ratio
-0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?